Lawrence Lamb, EVP and CSO at IN8BIO, INC. (INAB), bought 526 shares at $1.90 ($999) on 2022-08-16, disclosed to the SEC on 2022-08-18.
Open-market purchase of $999 INAB by EVP and CSO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.